Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BEVACIZUMAB vs BICALUTAMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BEVACIZUMAB vs BICALUTAMIDE: Safety Overview

Metric BEVACIZUMAB BICALUTAMIDE
Total FAERS Reports 78,112 4,061
Deaths Reported 17,498 462
Death Rate 22.4% 11.4%
Hospitalizations 23,114 1,486
Average Patient Age 61.1 yrs 71.9 yrs
% Female Patients 55.0% 2.1%
FDA Approval Date N/A Aug 28, 2009
Manufacturer Biocon Biologics Inc. Proficient Rx LP
Route INTRAVASCULAR ORAL
Marketing Status Prescription Prescription